0001104659-23-102823.txt : 20230921
0001104659-23-102823.hdr.sgml : 20230921
20230921161517
ACCESSION NUMBER: 0001104659-23-102823
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20230919
FILED AS OF DATE: 20230921
DATE AS OF CHANGE: 20230921
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: Groman Dan
CENTRAL INDEX KEY: 0001881296
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 001-40949
FILM NUMBER: 231269269
MAIL ADDRESS:
STREET 1: C/O ENFUSION INC.
STREET 2: 125 SOUTH CLARK STREET STE. 750
CITY: CHICAGO
STATE: IL
ZIP: 60603
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: Enfusion, Inc.
CENTRAL INDEX KEY: 0001868912
STANDARD INDUSTRIAL CLASSIFICATION: SERVICES-PREPACKAGED SOFTWARE [7372]
IRS NUMBER: 000000000
STATE OF INCORPORATION: DE
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: 125 SOUTH CLARK STREET, SUITE 750
CITY: CHICAGO
STATE: IL
ZIP: 60603
BUSINESS PHONE: (312) 253-9800
MAIL ADDRESS:
STREET 1: 125 SOUTH CLARK STREET, SUITE 750
CITY: CHICAGO
STATE: IL
ZIP: 60603
4
1
tm2326639-1_4seq1.xml
OWNERSHIP DOCUMENT
X0508
4
2023-09-19
0
0001868912
Enfusion, Inc.
ENFN
0001881296
Groman Dan
C/O ENFUSION, INC.
125 SOUTH CLARK STREET SUITE 750
CHICAGO
IL
60603
0
1
0
0
Chief Technology Officer
1
Class A Common Stock
2023-09-19
4
S
0
5000
9.07
D
143828
D
The transaction reported in this Form 4 was effected pursuant to a Rule 10b5-1 trading plan that was adopted by the reporting person on June 15, 2023.
The price reported in Column 4 is a weighted average price. The shares were sold in multiple transactions at prices ranging from $9.00 to $9.12. Full information regarding the number of shares sold at each separate price will be furnished to the SEC staff upon request.
/s/ Matthew Campobasso, as Attorney-in-Fact
2023-09-21